View in EDS HTML Full Text PDF Full Text

Dimdazenil for the treatment of insomnia: a systematic review and narrative synthesis: Dimdazenil for Insomnia.

Saved in:
Bibliographic Details
Title: Dimdazenil for the treatment of insomnia: a systematic review and narrative synthesis: Dimdazenil for Insomnia.
Authors: Ran, Shan (AUTHOR), Liu, Shouhuan (AUTHOR), Yan, Kewen (AUTHOR), Li, Xueyi (AUTHOR), Wu, Min (AUTHOR), Peng, Hanrui (AUTHOR), Liu, Tieqiao (AUTHOR), Li, Zejun (AUTHOR)
Source: Neurological Sciences. Mar2025, Vol. 46 Issue 3, p1179-1190. 12p.
Subjects: Sleep latency, Sleep duration, Sleep, Drug residues, Sleep disorders
Abstract: Background: Insomnia is a common sleep disorder affecting approximately 10-20% of adults worldwide. Despite various available treatment modalities, significant gaps remain in improving sleep maintenance and reducing functional impairments. Objective: To systematically review and synthesize studies on the efficacy and safety of Dimdazenil for the treatment of insomnia. Methods: A comprehensive search of multiple databases and websites was conducted to identify published and unpublished trials from inception to July 19, 2024. Due to the limited number of studies available, quantitative data were synthesized narratively. Results: This synthesis included four randomized controlled trials. The primary efficacy endpoints of these studies met the predetermined criteria for superiority. Dimdazenil significantly improved certain objective and subjective sleep measures in patients with insomnia, including reduced sleep latency and longer total sleep duration. Importantly, these outcomes were achieved without causing significant excessive daytime drowsiness or impairing daytime functionality. Furthermore, Dimdazenil demonstrated a generally acceptable safety profile and was well tolerated. Most evaluation indicators related to withdrawal symptoms, drug residues, and rebound effects did not show significant statistical differences. Limitations: The number of included studies and sample sizes were small, and there is a lack of data on the long-term efficacy and safety of Dimdazenil. Conclusions: Dimdazenil offers significant benefits in improving sleep onset and maintenance in patients with insomnia. It presents a favorable safety and tolerability profile while preserving daytime functioning. Future studies should extend the duration and scale to assess the long-term efficacy and safety of Dimdazenil across diverse populations. [ABSTRACT FROM AUTHOR]
Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 183073198
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dimdazenil for the treatment of insomnia: a systematic review and narrative synthesis: Dimdazenil for Insomnia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Ran%2C+Shan%22">Ran, Shan</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Shouhuan%22">Liu, Shouhuan</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yan%2C+Kewen%22">Yan, Kewen</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Xueyi%22">Li, Xueyi</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wu%2C+Min%22">Wu, Min</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Peng%2C+Hanrui%22">Peng, Hanrui</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Tieqiao%22">Liu, Tieqiao</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Zejun%22">Li, Zejun</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Neurological+Sciences%22">Neurological Sciences</searchLink>. Mar2025, Vol. 46 Issue 3, p1179-1190. 12p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Sleep+latency%22">Sleep latency</searchLink><br /><searchLink fieldCode="DE" term="%22Sleep+duration%22">Sleep duration</searchLink><br /><searchLink fieldCode="DE" term="%22Sleep%22">Sleep</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+residues%22">Drug residues</searchLink><br /><searchLink fieldCode="DE" term="%22Sleep+disorders%22">Sleep disorders</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Background: Insomnia is a common sleep disorder affecting approximately 10-20% of adults worldwide. Despite various available treatment modalities, significant gaps remain in improving sleep maintenance and reducing functional impairments. Objective: To systematically review and synthesize studies on the efficacy and safety of Dimdazenil for the treatment of insomnia. Methods: A comprehensive search of multiple databases and websites was conducted to identify published and unpublished trials from inception to July 19, 2024. Due to the limited number of studies available, quantitative data were synthesized narratively. Results: This synthesis included four randomized controlled trials. The primary efficacy endpoints of these studies met the predetermined criteria for superiority. Dimdazenil significantly improved certain objective and subjective sleep measures in patients with insomnia, including reduced sleep latency and longer total sleep duration. Importantly, these outcomes were achieved without causing significant excessive daytime drowsiness or impairing daytime functionality. Furthermore, Dimdazenil demonstrated a generally acceptable safety profile and was well tolerated. Most evaluation indicators related to withdrawal symptoms, drug residues, and rebound effects did not show significant statistical differences. Limitations: The number of included studies and sample sizes were small, and there is a lack of data on the long-term efficacy and safety of Dimdazenil. Conclusions: Dimdazenil offers significant benefits in improving sleep onset and maintenance in patients with insomnia. It presents a favorable safety and tolerability profile while preserving daytime functioning. Future studies should extend the duration and scale to assess the long-term efficacy and safety of Dimdazenil across diverse populations. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=183073198
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10072-024-07872-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 1179
    Subjects:
      – SubjectFull: Sleep latency
        Type: general
      – SubjectFull: Sleep duration
        Type: general
      – SubjectFull: Sleep
        Type: general
      – SubjectFull: Drug residues
        Type: general
      – SubjectFull: Sleep disorders
        Type: general
    Titles:
      – TitleFull: Dimdazenil for the treatment of insomnia: a systematic review and narrative synthesis: Dimdazenil for Insomnia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ran, Shan
      – PersonEntity:
          Name:
            NameFull: Liu, Shouhuan
      – PersonEntity:
          Name:
            NameFull: Yan, Kewen
      – PersonEntity:
          Name:
            NameFull: Li, Xueyi
      – PersonEntity:
          Name:
            NameFull: Wu, Min
      – PersonEntity:
          Name:
            NameFull: Peng, Hanrui
      – PersonEntity:
          Name:
            NameFull: Liu, Tieqiao
      – PersonEntity:
          Name:
            NameFull: Li, Zejun
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: Mar2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 15901874
          Numbering:
            – Type: volume
              Value: 46
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Neurological Sciences
              Type: main
ResultId 1